title: The potential benefits of a garlic and hydrochlorothiazide combination as antihypertensive and cardioprotective in rats.
abstract: The purpose of the present study was to investigate the protective effects of combined therapy of garlic homogenate and hydrochlorothiazide (HCTZ) in animals with hypertension and myocardial damage. Three weeks of high fructose (10% w/v) in fluid to albino rats resulted in hypertension. They were subsequently administered garlic (125, 250 and 500 mg/kg, 3 weeks in separate groups) and HCTZ (10 mg/kg, 6th week) once daily in their respective groups. At the end of 6 weeks, myocardial damage was induced by subcutaneous administration of isoproterenol (175 mg/kg) for 2 consecutive days. The results showed that garlic and HCTZ increase the lactate dehydrogenase, creatinine phosphokinase, superoxide dismutase and catalase activities in heart homogenate when used concurrently or separately. Further, restoration of normal values in fluid/food intake, body weight, systolic blood pressure, cholesterol, triglycerides, glucose and histopathological scores were observed in all treated groups. Furthermore, histological disturbances and hypertension were significantly ameliorated in treated animals. Moreover, moderate dose of garlic was more effective than low dose, while a high dose of garlic was least effective in correcting electrocardiographic changes. Thus it is concluded that garlic in moderate dose (250 mg/kg) with added HCTZ possesses synergistic cardioprotective and antihypertensive properties against fructose- and isoproterenol-induced toxicities.
authors.affiliation: Department of Pharmacology, Krupanidhi College of Pharmacy, Varthur Hobli, Chikkabellandur Village, Carmalaram Post, Bangalore 560 035, India. basheer_1@rediffmail.com
authors.forename: Syed Mohammed Basheeruddin
authors.initials: SM
authors.lastname: Asdaq
authors.forename: Mohammed Naseeruddin
authors.initials: MN
authors.lastname: Inamdar
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000737:chemistry / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D005260:Female; D005737:Garlic / Q000737:chemistry*; D006321:Heart / Q000187:drug effects*; D006852:Hydrochlorothiazide / Q000494:pharmacology*; D007545:Isoproterenol / Q000633:toxicity; D009206:Myocardium / Q000473:pathology; D010936:Plant Extracts / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000959:Antihypertensive Agents; D010936:Plant Extracts; D006852:Hydrochlorothiazide; D007545:Isoproterenol
references.citation: J Cell Physiol. 1994 Jan;158(1):133-9
references.pmid: 8263020
references.citation: Basic Res Cardiol. 1995 Nov-Dec;90(6):467-74
references.pmid: 8773192
references.citation: J Am Coll Cardiol. 2004 Nov 16;44(10):1996-2002
references.pmid: 15542282
references.citation: Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):127-36
references.pmid: 20112816
references.citation: Arch Biochem Biophys. 1988 Sep;265(2):362-72
references.pmid: 3421711
references.citation: J Pharmacol Exp Ther. 1998 Jul;286(1):429-38
references.pmid: 9655888
references.citation: Clin Chem. 1983 Mar;29(3):538-42
references.pmid: 6825269
references.citation: Lab Invest. 1981 May;44(5):426-33
references.pmid: 7230729
references.citation: J Ethnopharmacol. 2004 Nov;95(1):57-61
references.pmid: 15374607
references.citation: Nature. 1993 Apr 29;362(6423):801-9
references.pmid: 8479518
references.citation: Drugs. 1994 May;47(5):711-33
references.pmid: 7520854
references.citation: Int J Cardiol. 2007 Feb 14;115(3):326-33
references.pmid: 16828181
references.citation: BMC Pharmacol. 2002 Aug 16;2:16
references.pmid: 12182765
references.citation: J Med Food. 2006 Summer;9(2):205-13
references.pmid: 16822206
references.citation: Carcinogenesis. 1987 Aug;8(8):1155-7
references.pmid: 3608098
references.citation: Eur Heart J. 1993 May;14(5):677-81
references.pmid: 7685286
references.citation: Natl Med J India. 2000 Nov-Dec;13(6):304-10
references.pmid: 11209486
references.citation: Chem Biol Interact. 2009 Oct 30;181(3):472-9
references.pmid: 19660444
references.citation: N Engl J Med. 1997 Apr 17;336(16):1117-24
references.pmid: 9099655
references.citation: J Clin Invest. 1998 Oct 1;102(7):1377-84
references.pmid: 9769330
references.citation: J Clin Invest. 1984 Nov;74(5):1792-802
references.pmid: 6501571
references.citation: N Engl J Med. 2001 Jan 4;344(1):3-10
references.pmid: 11136953
references.citation: N Engl J Med. 1989 May 4;320(18):1177-82
references.pmid: 2624617
references.citation: Fitoterapia. 2001 May;72(4):402-5
references.pmid: 11395263
references.citation: J Trop Pediatr. 2001 Jun;47(3):181-5
references.pmid: 11419685
references.citation: J Ethnopharmacol. 2001 Aug;76(3):215-21
references.pmid: 11448541
references.citation: Am J Cardiol. 1990 Mar 6;65(10):4E-9E; discussion 22E-23E
references.pmid: 2178377
references.citation: J Mol Cell Cardiol. 1985 Apr;17(4):291-306
references.pmid: 3894676
references.citation: J Am Soc Nephrol. 1990 Jul;1(1):43-52
references.pmid: 2104250
references.citation: Clin Chem. 1982 Oct;28(10):2077-80
references.pmid: 6812986